The Utility of Urine Drug Screening

Similar documents
Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing Methods 3-5

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017

Testing for Controlled Substances

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Urine drug testing it s not always crystal clear

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

Conflict of Interest Disclosure

Urine Drug Screening (UDS) Dr. Erica L. Weinberg December 2017

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

URINE DRUG TOXICOLOGY

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

The Drug Testing Process. Employer or Practice

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies. 9/20/17

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Drug Screening: Things You Need to Know

Pain Medication Management Program Supports Patient Outcomes and Adherence

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Drug Testing: How to Evaluate Results

Pain Medication Management Program Monitors Patient Compliance

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

DRUGS OF ABUSE

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Does ultram show up as an opiate

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient

Cutoff levels for hydrocodone in a blood test

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Prescribing Opioid for. Opioid Naïve Patients AN OPIOD RX

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Drug Testing Basics. by Erowid

Treatment Agreements Clinical Contracts. Dr. Paul A. Farnan, Dr. Johan Wouterloot Prescribers Course, Vancouver, BC, Canada October 13, 2017

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening

A Toxicologists View of Addiction

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective

Urine Testing for Opioids

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

Practical Applications of Urine Drug Monitoring in the Addiction Treatment Setting

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

T R A I N I N G G U I D E

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Laboratory Service Report

Drug & Alcohol Testing in. Canada. Point of Care Testing

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

Beating Drug Tests and Defending Positive Results

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

Goals decided with patient: Mild-to-Moderate Pain First- line: codeine or tramadol Second-line: morphine, oxycodone or hydromorphone

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Drug Adherence Assessment Report

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

EDUCATIONAL COMMENTARY METHADONE

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Evaluation of the Integrated E-Z Split Key Cup II for Rapid Detection of Twelve Drug Classes in Urine

DrugConfirm Advanced Urine Dip Cards.

Drug Testing in Pain Management and Substance Use Disorder Treatment

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need

Fastect II Drug Screen Dipstick Test Training and Certification Program

Urine Drug Testing - What Do the Results Mean and What Do I Tell the Patient? Andrea Trescot, MD, FIPP

Dr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei

MEDICAL POLICY Drug Testing

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:

POINT OF CARE TESTING

Urine Drug Testing PracticeNotes Clinical Guide

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Rapid Alcohol Screening Devices. p19

Clearing Up The Confusion About Substance Abuse Testing

Urine Drug Testing In Pain Management and Substance Abuse Treatment Corporate Medical Policy

Forensic Toxicology Scope of Testing and Detection Limits

Urine Opioid Dependency Panel (UODP) 1

MEDICAL POLICY Drug Testing

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

Product Catalog. Rapid Alcohol Screening Devices. p24. Rapid Urine Screening Devices. p4. Rapid Oral Fluid Screening Devices. p18

TRIM reference DD17/ Endorsed by Publication date Review date

Chronic Opioid Therapy Safe Prescribing in Primary Care. Part 3

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Urine Drug Screening: The Essentials of Interpretation

Does tramadol test positive

INTERPATH LABORATORY, INC. TEST UPDATES

Transcription:

The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO

Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical, including photocopying, recording, or information storage and retrieval systems without prior written permission of Sea Courses Inc. except where permitted by law. Sea Courses is not responsible for any speaker or participant s statements, materials, acts or omissions.

LEARNING OBJECTIVES 1. Appreciate Urine Drug Testing as a Risk Mitigation Strategy 2. Learn the two types of Urine Drug Screens 3. Understand which and what to order on UDS 4. Interpret UDS results with more confidence 5. Understand when to do further testing of positive (and negative) UDS 6. Develop a plan for urine drug screening in the office

Canadian Guidelines Risk Mitigation Expert Guideline 6: Urine Drug Screening Baseline UDS for starting or receiving opioids Repeated UDS based on risk Ask about all medications, drugs recently taken, understand UDS, false positive, false negative

Types of Urine Drug Tests 1. Qualitative (Screening) Assays Identifies drugs/metabolites with variable specificity and sensitivity by drug class Either Point of Care or at the Lab 2. Quantitative (Confirmatory) Assays Identifies and quantifies individual drugs/metabolites with high specificity and sensitivity with defined cuttoff limits Only at the Lab

What s in a UDS? Point of care testing now available and reliable for: Opiates Benzos (except Clonazepam) Cocaine Amphetamines *** Methamphetamines Oxycodone EtOH Methadone (EDDP) Fentanyl Buprenorphine MDMA But Not Hydromorphone!

Metabolism of Opioids http://thepainsource.com/metabolism-of-

UDS LIMITATIONS Opiates Codeine, Morphine, Heroin (6-MAM morphine), Hydrocodone, Hydromorphone, poppy seeds Cocaine Benzoylecgonine, highly specific Oxycodone Oxycodone Benzos Clonaz not detected Methadone (Metabolites) EDDP, need to request Fentanyl Need to ask specifically Hydromorphone No Immunoassay, only GCMS Amphetamine/Methamph need to request LOTS of cros reaction (cold medication, ephedrine, pseudoephedrine) THC Nabilone (Cesamet does not contain THC and is NOT detected in UDS) Marinol and Sativex are +

UDS LIMITATIONS Useful for assessing what the patient is taking What is NOT in the urine is just as important as what is present Hydromorphone is variably detected (under opiate ) Fentanyl is NOT detected in all kits requires a specific EIA Some benzos are variably detected the EIA used is the antibody for diazepam clonazepam may not show up Sertraline and citalopram can give a false positive for benzos Tests do not tell how much is being used or the frequency of use Cannot distinguish if patient is taking it as directed.

Substance Urine Blood Alcohol Amphetamines (except meth) 3 5 days via ethyl gluconoride (EtG) metabolite or 6-24 hours via traditional method 12 hours 1 to 3 days 12 hours Methamphetamine 3 to 5 days 1-3 days MDMA 4 days 25 hours Barbiturates (except phenobarbital) 2 to 3 days 1 to 2 days Phenobarbital 2 to 3 weeks 4 to 7 days Benzodiazepines Cannabis Cocaine Therapeutic use: 3 days. Chronic use (over one year): 4 to 6 weeks Single use: 1-6 days Weekly use: 3-9 days Daily use: 7-30 days 2 to 4 days with exceptions for certain kidney disorders 6 to 48 hours 2-3 days after infrequent use, up to 2 weeks after frequent use 24 hours Codeine 1 day 12 hours Morphine 2 days 6 hours Heroin 3 to 4 days 6 hours LSD 24 to 72 hours (however tests for LSD are very uncommon) 0 to 3 hours Methadone 3 days 24 hours PCP 3 to 7 days for single use; up to 30 days in chronic users 1 to 3 days

What does a positive UDS result really mean? Patient is compliant/adherent (took prescribed drug as directed) Patient added drug to urine after collection Patient took one dose prior to collection (but really non-compliant) Patient took another drug which also crossreacts with Ab Test Collection or Lab error/mix-up False positive

What does a Negative UDS result really mean? Patient is NOT compliant/adherent Patient took the drug less than prescribed (PRN) Altered pharmacokinetic variables Drug not absorbed Altered metabolism or elimination Diluted or adulterated sample Test doesn t x-react with drug of interest (ie oxycodone not picked up on opiate screen) Collection or Lab error/mix-up False negative Drug present, but below cutoff/detection limit

Limitations of Immunoassay False Negative and Detection Limits Variables Assay Cuttoff Assay Vendor Drug formulation/dose Pt pharmacokinetics Sample type Collection time from LD Specimen integrity/quality

Limitations Interferences Classic adulterants bleach, soap, liquid drain cleaner, white vinegar, glutaraldehyde, sodium nitrite, and pyridinium chlorochromate. Commercial adulterants, Urine Luck version 6.3, Stealth, Clean-X, Klear, Purafyzit, Instant Clean, Krystal Kleen, and UR n Kleen. Klear: is made of nitrite and affects the tetrahydrocannibinol (THC) confirmation process but not the immunoassay process.

Limitations Adulteration Diluting sample (artificially and biologically) Check SG and ph Using someone else s sample Use thermometers Use bluing liquid in toilets Observed sample collection

Oh, oh...not what I was expecting Retake history of medication/drug use in past week non-accusatory Advise patient of false positive and false negative Give patient opportunity to address any positive (and negative) results Ensure not lab error Request confirmation ON SAME SAMPLE

Confirmatory Testing GC/MS or LC/MS Very Specific, highly sensitive Still have issues related to drug presence vs impairment and intoxication due to drug Still have issues related to sample adulteration

Alcohol use Considered to be much more troublesome and much more widespread. Physicians frequently prescribed morphine to alcoholics without knowing how much they drink. Need to order EtOH specifically (24 hrs only)

Urine Drug Screen 1. GC Mass Spectroscopy 2. Or Thin Layer Chromotography 3. Hydromorphone 4. Salicylate Level 5. EthOH level 6. Acetaminophen Level for as needed confirmation

Case 57 M w/ chronic low back pain for 15 years after being thrown out of a jeep After 8 weeks pt still experiencing significant pain that is negatively affecting function; you start opioids (MSContin 15 mg TID titrated to 30 mg TID) to good effect: improved pain and function One month later, routine UDT positive for cocaine and Opiates

What was done/should have been done in advance Comprehensive approach to high-quality management of chronic pain Treatment agreement: discussion with pt about risk and benefits Fair warning that UDTs would be done Fair warning that + UDT might mean discontinuing opioids Practice-wide decision about how treatment agreement violations handled

What to do now? Get GC/MS confirmation of any unexpected result (if confirmed) Talk to patient, reveal result of test, ask him what he used, how long, how much, etc Show empathy but do not allow patient to dispute results Show empathy but do not allow patient to shift blame: I did it because my pain was out of control/you are not treating my pain Based on practice policy, begin opioid taper (1-2 week follow up with rudt) Consider addiction referral based on your assessment

Summary Identifies more misuse than self-report or physician impression Which test to order? Immunoassay as screen Lab or POC Gas chromotography/mass spectroscopy for confirmation recommend doing this any time you get an unexpected result Always ask and document recent intake before sending test

How to discuss UDT This is our routine practice. We want to ensure your safety.

Audience Survey How often do you think a UDS should be done? Consider risk: For opioid misuse or addiction Aberrant drug-related behaviour More frequently for higher risk (Q 2-4 wks) Less frequently for low risk (1-4 times/yr)

Audience Survey Should you do RANDOM UDS? Consider risk: Random Testing for high risk Preselect dates and have MOA call Allow 24 hrs for patient to provide sample

Audience Survey Should you collect UDS at every visit? OK to collect at every visit, but better to collect at SOME visits Random Testing for high risk

Pearls You are not a police officer Your office requires a standard procedure for UDS UDS is an imperfect tool with many limitations Can still be a useful clinical tool Need to clinical reasoning with interpretation Document Meds/drugs hx UDS interpretation Plan for action

Thank you